National Observational Study of Clinical Practices in Deceased Organ Donation
- Conditions
- Deceased Organ DonationTransplantationCritical Illness
- Registration Number
- NCT03114436
- Lead Sponsor
- McMaster University
- Brief Summary
This is a 1-year national prospective cohort study that observes the medical management of consented deceased organ donors at hospitals across Canada with a high volume of deceased donation.
- Detailed Description
This prospective cohort study enrols consecutive adult deceased organ donors with a waiver of research consent and collects various data related to deceased donor care in the ICU from the time of consent for donation to the time of organ recovery. Clinical data includes donor characteristics, type of donation (after neurological death or cardiocirculatory death), resuscitation methods, cardiopulmonary monitoring techniques, medications, blood work, mechanical ventilation, diagnostic imaging, complications, and methods of death declaration. Various clinical data on deceased donors are collected prospectively from the time of consent for organ donation up to and including the day of organ recovery.
The Canada-DONATE study is designed to develop a national platform for future clinical trials in deceased donor care. The main objectives include:
1. Establish specialized organ donation research teams at participating ICUs.
2. Observe, record, and describe ICU practices in deceased donor care (e.g., donor resuscitation, organ suitability assessments, death declaration) which are likely to vary by site, region and province and will be very important to inform clinical care protocols for future RCTs.
3. Engage and work with ODOs from each province to foster data sharing and develop procedures to enhance efficiency in future RCTs.
4. Investigate the comparative effectiveness of various ICU interventions in deceased donor care to improve the conversion of consented donors to actual donors and to improve the number of transplants per donor.
5. Produce specific knowledge translation tools that will serve in the future as clinical tools to enhance ICU care and research tools to facilitate RCTs.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 622
- Admitted into a critical care area (ICU, CCU, ER)
- Consent has been obtained for Organ Donation
- Admitted into a paediatric critical care area (NICU, PICU)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence to national guidelines for deceased donor care Duration of deceased donor care in the ICU (1-5 days per donor). For each donor, we will measure adherence to multiple recommendations from national guidelines for the management of deceased organ donors.
- Secondary Outcome Measures
Name Time Method Organ transplantation Transplantation may occur from 1-5 days from the time of consent. Deceased organ donors can provide up to 8 organ donations each. We will measure the number of transplants that proceed from each consented donor.
Organ donation Duration of deceased donor care in the ICU (1-5 days per donor). This refers to the conversion of a consented organ donor to an actual organ donor.
Trial Locations
- Locations (29)
Foothills Medical Centre
🇨🇦Calgary, Alberta, Canada
Royal Alexandra Hospital
🇨🇦Edmonton, Alberta, Canada
University of Alberta Hospital
🇨🇦Edmonton, Alberta, Canada
Royal Columbian Hospital
🇨🇦New Westminster, British Columbia, Canada
Vancouver General Hospital
🇨🇦Vancouver, British Columbia, Canada
St. Paul's Hospital
🇨🇦Vancouver, British Columbia, Canada
Royal Jubilee Hospital
🇨🇦Victoria, British Columbia, Canada
Victoria General Hospital
🇨🇦Victoria, British Columbia, Canada
Hamilton Health Sciences - Hamilton General Hospital
🇨🇦Hamilton, Ontario, Canada
Hamilton Health Science - Juravinski Hospital
🇨🇦Hamilton, Ontario, Canada
Scroll for more (19 remaining)Foothills Medical Centre🇨🇦Calgary, Alberta, Canada